NCT06124391

Novel Subtypes of Polycystic Ovary Syndrome

Name: Clinical Trial NCT06124391
Creator: Shandong University
Keywords: Polycystic Ovary Syndrome, Long-term follow-up, other, clinical trial, Brazil,China,Singapore,Sweden,Turkey,United States of America

An Evidence-Based Novel Subtypes of Polycystic Ovary Syndrome and Their Association With Outcomes: a Large Cohort Study

Shandong University·ClinicalTrials.gov·otherRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Polycystic Ovary Syndrome
Drug/Device/Intervention: Long-term follow-up
Study type: Observational
Intervention type: other

Sponsor & location

Primary sponsor: Shandong University
Location: Hershey,Porto Alegre,Chengdu,Guangzhou,Jinan,Shanghai,Tianjin,Yinchuan,Singapore,Solna,Ankara, Brazil,China,Singapore,Sweden,Turkey,United States of America

Timeline & enrollment

Phase: N/A
Start date: Jan 01, 2021
End date: Dec 30, 2025
Enrollment: 50000 participants

Primary outcome

Persistence of PCOS Diagnosis,Changes in PCOS Subtype,Body Mass Index,Non-Alcoholic Fatty Liver Disease (NAFLD),Hypertension,Type 2 Diabetes Mellitus (T2DM),Dyslipidemia,Total live birth rate,Clinical pregnancy rate,Pregnancy loss rate,Maternal and neonatal complications

Summary

To classify subtypes of Polycystic Ovary Syndrome (PCOS) using machine-learning algorithms, and compare the reproductive and metabolic characteristics and IVF outcomes across these identified subtypes.

ICD-10 classifications

Polycystic ovarian syndromeOvarian dysfunction, unspecifiedOvarian dysfunctionOther ovarian dysfunctionNeoplasm of uncertain or unknown behaviour: Ovary

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06124391
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06124391 through Pure Global AI's free database. This phase not specified trial is sponsored by Shandong University and is currently Recruiting. The study focuses on Polycystic Ovary Syndrome. Target enrollment is 50000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.